Download PDF

Register to download the report. Already a member?

Sign Up


62462 1502285060HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Pharma Stories & Articles


The Indonesian Halal Law: A Headache for Pharma

The Halal Product Assurance Law, enacted in 2014 and due to be implemented across Indonesia in 2019, will mandate that all food and drink that that enters, is distributed, and is traded in Indonesia must be halal certified. However, the …


Countering the Rise of Non Communicable Diseases in Algeria

Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and unchecked throughout the African continent to the point where they …


Expanscience Mexico along with its key brand Mustela reveals the physiology of babies’ skin via a 10 year research called E.V.E.I.L.S.

More about Laboratoire Expanscience Mexico : More about Mustela Mexico :


Sources of Disruption in Today’s Pharma Industry

PharmaBoardroom’s readers were polled on what they felt was the most disruptive force in the pharmaceutical industry today. Possible answers were big data and digitalization, patient-centricity, economic austerity, and advancements in supply chain management. Big Data and Digitalization Overall, most …


Round Table Discussion on Algerian Public Healthcare Provision

In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social …


FDA New Drug Approvals 2017

In 2016, rumours of a weakening FDA followed a disappointing 16 new drugs approved for the full year. However, since the beginning of 2017 the FDA has approved 26 drugs; double the amount of the mid-year average since 2007. “The …


Kobe: A Center of Excellence for Biomedical Innovation

Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe Foundation for Biomedical Research and Innovation (FBRI), discusses the central Japanese city of Kobe’s significant potential as a cutting-edge R&D hub for both …


The Evolution of Algeria’s Healthcare and Pharmaceuticals System

This chart shows how Algeria’s pharmaceuticals and healthcare system has evolved over time; from the creation of the Algerian Central Pharmacy (PCA) back in 1962, all the way to the implementation of the ANPP in 2017. Click here to download …


Under the Skin of Success: Expanscience’s Mexican Strategy

Cédric Ertlé, general manager of Laboratoires Expanscience Mexico, explains how he has spearheaded his affiliate to remarkable growth in both the dermo-cosmetics and rheumatological segments. “There are 11 million Mexicans suffering from arthritis and only one million of them are …


Promoting Japanese Bio-industry Innovation

Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to PharmaBoardroom at the BIO 2017 conference in San Diego on the role of his organization within Japan and his mission to instill a start-up culture within …


Clinical Research in Mexico: Trials and Tribulations

According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be considered to have a healthy investment in this area. As Mexico currently only invests 1.8 percent …


Mexican Medtech: A Well Oiled Machine?

Mexico’s medical device segment displays promising growth indicators, with innovative companies providing integrated and digital solutions now firmly embedded within the healthcare landscape. However, regulatory obstacles as well as a lack of joined-up thinking in the public sector remain in …




Download PDF

First Name:

Last Name: